Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Tapering Instructions in TKR/THR
NCT03534102Phase 4Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 4, open-label trial (3 arms), sponsored by Brigham and Women's Hospital. Primary endpoints: Total Opioid Consumption: Amount, Opioid Usage After One Week at 1 week and 1 more. Planned start Jun 2022; status: withdrawn.
Beyond the preview
Go deeper on NCT03534102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534102.